Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2361]
News [4942]
Articles [204]
Editorials [8]
Conferences [138]
elearning [14]
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru
Targeting BRAF V600E in metastatic colorectal cancer: where are we today? ( Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru )
9 May 2023
War in Ukraine: Support from Lymphoma Coalition for Ukrainian haematological...
Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain
War in Ukraine: Support from Lymphoma Coalition for Ukrainian haematological cancer patients ( Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain )
9 May 2023
Collective efforts to combat cancer in Cambodia
Her Excellency Dr Or Vandine - Secretary of State, Ministry of Health, Cambodia
Collective efforts to combat cancer in Cambodia ( Her Excellency Dr Or Vandine - Secretary of State, Ministry of Health, Cambodia )
5 May 2023
Adding new vaccine type to leading immunotherapy dramatically reduces melanoma...
Dr Jeffrey Weber - NYU Langone’s Perlmutter Cancer Center, Newyork, USA
Adding new vaccine type to leading immunotherapy dramatically reduces melanoma recurrence ( Dr Jeffrey Weber - NYU Langone’s Perlmutter Cancer Center, Newyork, USA )
3 May 2023
Pembro plus gemcitabine and cisplatin potential option for metastatic or...
Dr Katie Kelley - University of California San Francisco, San Francisco, USA
Pembro plus gemcitabine and cisplatin potential option for metastatic or unresectable biliary tract cancer ( Dr Katie Kelley - University of California San Francisco, San Francisco, USA )
2 May 2023
Patient-derived iPSCs faithfully represent the genetic diversity and cellular...
Dr Eirini Papapetrou - Icahn School of Medicine at Mount Sinai, New York, USA
Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of AML ( Dr Eirini Papapetrou - Icahn School of Medicine at Mount Sinai, New York, USA )
28 Apr 2023
Applying the syndemic framework to cancer research for effective cancer control...
Dr Zahid Butt - University of Waterloo, Waterloo, Canada
Applying the syndemic framework to cancer research for effective cancer control in LMICs ( Dr Zahid Butt - University of Waterloo, Waterloo, Canada )
27 Apr 2023
Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC
Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh...
Cetuximab with XELOX or XELIRI is tolerable and effective in RAS wild-type mCRC ( Dr Jamal Zekri - King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia )
27 Apr 2023
Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes...
Dr Joshua Choe - Columbia University, New York City, USA
Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death ( Dr Joshua Choe - Columbia University, New York City, USA )
27 Apr 2023
Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non...
Prof Peter Szlosarek - Barts Cancer Institute, London, UK
Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma ( Prof Peter Szlosarek - Barts Cancer Institute, London, UK )
26 Apr 2023
Breast and emerging indications for IORT
Dr David Martinez Perez - AUNA, Lima, Peru
Breast and emerging indications for IORT ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023
The advantages of IORT for early breast cancer treatment
Dr David Martinez Perez - AUNA, Lima, Peru
The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )
26 Apr 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation